Empagliflozin, a diabetes drug that increased lifespan in mice, is being studied to see if it can slow down age-related kidney decline in non-diabetic people.

Instead of increasing a statin's dosage to lower cholesterol, adding Ezetimibe can be more effective and result in fewer side effects.

Finasteride may not cause more aggressive prostate cancer but rather improves its detection by shrinking the prostate, a phenomenon known as detection bias.

The speaker takes a 1mg dose of finasteride, which is lower than the 5mg dose used in clinical trials, hoping it's sufficient when started at a younger age.

The PESA study showed that even when all other risk factors like inflammation are optimal, high LDL cholesterol is still directly correlated with blockages in blood vessels.

Research suggests the optimal LDL cholesterol level may be the level present at birth, which is an aggressive target of 20 to 40 milligrams per deciliter.

Low-dose statins can offer 70-80% of the benefits of high-dose statins but with a much lower risk of side effects.

Rosuvastatin is a good choice because it is hydrophilic, meaning it doesn't readily cross the blood-brain barrier or accumulate in muscles.